Table 2.

CPIC (2016). Assignment of CYP2C19 Phenotype based on Genotype.

PhenotypeGenotypeExamples of diplotypes
CYP2C19 ultrarapid metabolizer
(approximately 2˗5% of individuals)a		An individual who has 2 increased function alleles *17/*17
CYP2C19 rapid metabolizer
(approximately 2‑30% of individuals)		An individual who has one normal function allele and one increased function allele *1/*17
CYP2C19 normal metabolizer
(approximately 35‑50% of individuals)		An individual who has 2 normal function alleles *1/*1
CYP2C19 intermediate metabolizer
(approximately 18‑45% of individuals)		An individual who has one normal function allele and one no function allele, or one no function allele and one increased function allele *1/*2
*1/*3
*2/*17b
CYP2C19 poor metabolizer
(approximately 2‑15% of individuals)		An individual who has 2 no function alleles *2/*2
*2/*3
*3/*3
a

CYP2C19 metabolizer status frequencies are based on average multi-ethnic frequencies. See the CYP2C19 Frequency Tables for population-specific allele and phenotype frequencies (21).

b

The predicted metabolizer phenotype for the*2/*17 genotype is a provisional classification. The currently available evidence indicates that the CYP2C19*17 increased function allele is unable to completely compensate for the CYP2C19*2 no function allele.

This table is adapted from (21).

From: Flibanserin Therapy and CYP2C19 Genotype

Cover of Medical Genetics Summaries
Medical Genetics Summaries [Internet].
Pratt VM, Scott SA, Pirmohamed M, et al., editors.
Copyright Notice

All Medical Genetics Summaries content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license which permits copying, distribution, and adaptation of the work, provided the original work is properly cited and any changes from the original work are properly indicated. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.